Home / News
Waters Buys MOBILion to Expand Proteomics and Ion Mobility Tech
• Waters Corporation acquired MOBILion Systems to integrate SLIM high-resolution ion mobility separation into its mass spectrometry portfolio, strengthening complex proteomics analysis and expanding presence in a $2 billion market.
• CEO Udit Batra said pairing SLIM with Xevo MRT MS will accelerate proteomics research and support data-intensive AI workflows for biomarker discovery.
• MOBILion CEO Melissa Sherman said Waters’ separation science leadership will help move high-resolution ion mobility from research laboratories toward routine clinical testing worldwide.
• Financial terms were not disclosed, but the acquisition targets a proteomics LC-MS market growing at a high single-digit rate, according to Waters estimates.
Waters Corporation has acquired MOBILion Systems, Inc., a developer of SLIM high-resolution ion mobility separation technology, in a move that deepens its push into proteomics and strengthens its mass spectrometry capabilities. The transaction, announced on November 3, 2026, from Milford, Massachusetts, combines MOBILion’s SLIM separation platform with Waters’ Xevo MRT MS technology to improve the analysis of complex proteins, peptides and molecular mixtures. The company says the combination is intended to outperform liquid chromatography–mass spectrometry alone in bottom-up proteomics workflows.
Udit Batra, Waters’ president and chief executive, said the acquisition gives the company a distinctive position in proteomics, first in research and eventually in clinical applications. He emphasized that MOBILion’s team brings specialized expertise in ion mobility science, and that pairing SLIM with Waters’ speed, resolution and sensitivity should help scientists translate complex biological data into actionable insights. Waters also framed the deal as a way to generate large, high-quality datasets needed by artificial intelligence foundation and frontier models, supporting lab-in-the-loop workflows in life sciences.
The purchase advances Waters’ strategy to compete in proteomics, a market the company estimates at about $2 billion in total addressable market for liquid chromatography–mass spectrometry proteomics, growing at a high single-digit rate. Melissa Sherman, chief executive of MOBILion Systems, said SLIM was designed to resolve molecular features that other separation methods may miss. She added that Waters’ long record in separation science and mass spectrometry makes it a suitable home for the technology, especially when combined with Waters’ multi-reflecting time-of-flight systems. Sherman said the integration could help move SLIM from leading research laboratories into routine testing environments worldwide.
Financial terms of the acquisition were not disclosed. MOBILion is an instrumentation company focused on ion mobility technologies for the separation and characterization of complex molecules. Waters is a global life sciences and diagnostics group with about 15,000 colleagues, supplying analytical technologies, informatics and services for regulated, high-volume testing environments. The company said its portfolio supports pharmaceutical quality, food and water safety, earlier disease detection, management of routine infections and efforts to combat antibiotic resistance.